Ergomed is pleased to welcome Zizi Uzezi Imatorbhebhe, MBA, MS PMP® as the new Senior Vice President, Global Strategy & Development, Rare Disease.
Zizi is a seasoned executive with over 32+ years of drug development and commercial experience in the Bio-pharmaceutical, Clinical Research (CRO) and Healthcare industry. She has been instrumental in working collaboratively with many global sponsors especially in the Rare Disease space to identify drug development challenges for their programs and providing solutions to address them. She has also successfully commercialized over 25 pharmaceutical and medical device products globally. In addition, she works to leverage innovations to develop patient-oriented solutions and expand clinical trial access.
Her Educational background includes MS in Biotechnology from the University College London, UK MBA from Chapman University, California US, BS in Biochemistry from the University of Ibadan, Nigeria. In addition, she has an Executive Management Certificate in Disruptive Strategies and Innovation from Harvard Business School, Boston, US and is Lean Six Sigma trained.
Zizi has successfully developed and optimized Rare Disease Initiatives and Centers of Excellence at leading organizations and is a published subject matter expert in this space. She is passionate about bringing treatments to Rare Disease patients due to the high unmet need with 95% of Rare Diseases without treatment. Approximately 50 percentof rare diseases affect children, 30 percentof whom will not live to see their fifth birthday.
Zizi shared "Rare Disease development is one of the fastest-growing areas of drug development accounting for over 30% of compounds in development. I am excited to be expanding our global efforts to growing our Rare Disease Business, strengthening collaborations with biopharmaceutical sponsor companies, patient advocacy groups, innovative technology and service providers to accelerate rare disease drug development and bring much-needed treatments to patients around the world".
Please, join us in welcoming Zizi to the Ergomed Team!
If you require further information, please do not hesitate to contact us.
Ergomed plc published this content on 24 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 24 November 2021 13:09:06 UTC.